← Back to Vaccine Database

MVA-C + gp140/MF59

Live attenuated vaccine · VDDBV0526

Target & Classification

HIVHuman immunodeficiency virus
Live attenuated vaccine
HIV Infections
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT01418235 Phase 1HIV Infections